Selina Clifford, General Manager Australia and New Zealand at UCB, said, “Our ambition at UCB is to transform the lives of people living with severe and rare diseases such as myasthenia gravis. We are pleased to bring a new treatment option to healthcare professionals and Australians living with generalised myasthenia gravis.” …
Listing delivers access to targeted therapy for Australians living with myasthenia gravis
July 1, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
LTR Pharma secures national US manufacturing and fulfilment partner
July 21, 2026 - - Latest News -
Candidate shows antidepressant signal in difficult to treat depression
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News -
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News